HLN:NYSE
Haleon PLC - ADR
$9.94
0.00%
(0.00) 1D
$9.95
arrow_upward
+0.10% (+0.010)todayPre-market
Closed: Oct 15, 4:00:02 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HLN...
Mkt. cap
43.44B
Avg. vol.
19.82M
Volume
26.25K
Dividend
1.99%
Quarterly dividend
$0.05
Ex-dividend date
Aug 13, 2026
P/E ratio
20.69
52-wk high
$11.28
52-wk low
$8.65
EPS
$0.48
Beta
0.16
Shares outstanding
4.40B
No. of employees
25K
Mkt. cap
43.44B
Avg. vol.
19.82M
Volume
26.25K
Dividend
1.99%
Quarterly dividend
$0.05
Ex-dividend date
Aug 13, 2026
P/E ratio
20.69
52-wk high
$11.28
52-wk low
$8.65
EPS
$0.48
Beta
0.16
Shares outstanding
4.40B
No. of employees
25K
News stories
From web sources and news partners
ad-hoc-news.de
·
1 day ago
UBS trims Haleon growth forecast to 3.1 percent for Haleon stock
Profile
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022.
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Wikipedia
About Haleon PLC - ADR